These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8411115)

  • 1. Blockade of a KCa channel with synthetic peptides from noxiustoxin: a K+ channel blocker.
    Vaca L; Gurrola GB; Possani LD; Kunze DL
    J Membr Biol; 1993 Jun; 134(2):123-9. PubMed ID: 8411115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptides corresponding to the sequence of noxiustoxin indicate that the active site of this K+ channel blocker is located on its amino-terminal portion.
    Gurrola GB; Molinar-Rode R; Sitges M; Bayon A; Possani LD
    J Neural Transm; 1989; 77(1):11-20. PubMed ID: 2746197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaliotoxin, a novel peptidyl inhibitor of neuronal BK-type Ca(2+)-activated K+ channels characterized from Androctonus mauretanicus mauretanicus venom.
    Crest M; Jacquet G; Gola M; Zerrouk H; Benslimane A; Rochat H; Mansuelle P; Martin-Eauclaire MF
    J Biol Chem; 1992 Jan; 267(3):1640-7. PubMed ID: 1730708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noxiustoxin 2, a novel K+ channel blocking peptide from the venom of the scorpion Centruroides noxius Hoffmann.
    Nieto AR; Gurrola GB; Vaca L; Possani LD
    Toxicon; 1996 Aug; 34(8):913-22. PubMed ID: 8875778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic undecapeptide (NTX10-20) of noxiustoxin blocks completely the I(A) potassium currents of cerebellum granular cells.
    Frau A; Pisciotta M; Gurrola GB; Possani LD; Prestipino G
    Eur Biophys J; 2001; 29(8):569-73. PubMed ID: 11288831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional features of noxiustoxin: a K+ channel blocker.
    Gurrola GB; Possani LD
    Biochem Mol Biol Int; 1995 Oct; 37(3):527-35. PubMed ID: 8595393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of cell membrane potential in cultured vascular endothelium.
    Vaca L; Licea A; Possani LD
    Am J Physiol; 1996 Mar; 270(3 Pt 1):C819-24. PubMed ID: 8638662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxin pharmacology of the large-conductance Ca(2+)-activated K+ channel in the apical membrane of rabbit proximal convoluted tubule in primary culture.
    Tauc M; Congar P; Poncet V; Merot J; Vita C; Poujeol P
    Pflugers Arch; 1993 Oct; 425(1-2):126-33. PubMed ID: 7505914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of a K(+)-channel blocker from the scorpion Tityus cambridgei.
    Wang I; Wu SH; Chang HK; Shieh RC; Yu HM; Chen C
    Protein Sci; 2002 Feb; 11(2):390-400. PubMed ID: 11790849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subplasmalemmal ryanodine-sensitive Ca2+ release contributes to Ca2+-dependent K+ channel activation in a human umbilical vein endothelial cell line.
    Frieden M; Graier WF
    J Physiol; 2000 May; 524 Pt 3(Pt 3):715-24. PubMed ID: 10790153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evolutionarily conserved binding site for serine proteinase inhibitors in large conductance calcium-activated potassium channels.
    Moss GW; Marshall J; Morabito M; Howe JR; Moczydlowski E
    Biochemistry; 1996 Dec; 35(50):16024-35. PubMed ID: 8973172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of K+ channel blockers and cromakalim (BRL 34915) on the mechanical activity of guinea pig detrusor smooth muscle.
    Grant TL; Zuzack JS
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1158-64. PubMed ID: 1722252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of iberiotoxin block of the large-conductance calcium-activated potassium channel from bovine aortic smooth muscle.
    Giangiacomo KM; Garcia ML; McManus OB
    Biochemistry; 1992 Jul; 31(29):6719-27. PubMed ID: 1379069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and structure-functional characterization of phage display library-derived mimotopes of noxiustoxin, a neurotoxin of the scorpion Centruroides noxius Hoffmann.
    Gazarian T; Selisko B; Hérion P; Gazarian K
    Mol Immunol; 2000; 37(12-13):755-66. PubMed ID: 11275260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into alpha-K toxin specificity for K+ channels revealed through mutations in noxiustoxin.
    Mullmann TJ; Spence KT; Schroeder NE; Fremont V; Christian EP; Giangiacomo KM
    Biochemistry; 2001 Sep; 40(37):10987-97. PubMed ID: 11551194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of action of iberiotoxin, a potent blocker of the large conductance Ca(2+)-activated K+ channel.
    Candia S; Garcia ML; Latorre R
    Biophys J; 1992 Aug; 63(2):583-90. PubMed ID: 1384740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noxiustoxin and leiurutoxin III, two homologous peptide toxins with binding properties to synaptosomal membrane K+ channels.
    Valdivia HH; Martin BM; Escobar L; Possani LD
    Biochem Int; 1992 Sep; 27(6):953-62. PubMed ID: 1280139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charybdotoxin and noxiustoxin, two homologous peptide inhibitors of the K+ (Ca2+) channel.
    Valdivia HH; Smith JS; Martin BM; Coronado R; Possani LD
    FEBS Lett; 1988 Jan; 226(2):280-4. PubMed ID: 2448164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the stimulatory effect of resveratrol on Ca(2+)-activated K+ current in vascular endothelial cells.
    Li HF; Chen SA; Wu SN
    Cardiovasc Res; 2000 Mar; 45(4):1035-45. PubMed ID: 10728430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and regulation of Ca2+-dependent K+ channels in human esophageal smooth muscle.
    Hurley BR; Preiksaitis HG; Sims SM
    Am J Physiol; 1999 Apr; 276(4):G843-52. PubMed ID: 10198326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.